USCOM LIMITED — Regulatory Filings 2009

Mar 24, 2009

==> picture [71 x 87] intentionally omitted <==

MARKET ANNOUNCEMENT

• USCOM science presented in China

• Chinese pediatric publications

• 10 unit order for international market

Wednesday, 25th March 2009: Uscom (ASX Code: UCM) today announced the presentation of USCOM technology and science to the Critical Medicine Management Committee of the Traditional Chinese Medicine and Modern Medicine Institute in Tian Jin, China, by the Chairman and Director of Clinical Science of Uscom Rob Phillips.

The presentation was at the invitation of Professor Ren Xinsheng, the President of the Traditional Chinese Medicine and Modern Medicine Institute and was titled “Circulation; Measurement and management for all.” The presentation was accompanied by visits to some of the elite medical centres in Beijing.

Uscom CEO, Mr. Paul Butler said “There is increasing interest in China in USCOM and our approach to management of circulation, particularly in children. This presentation supports our Chinese Distributors, Pacific Medical Systems, and is expected to stimulate sales in the region.”

Mr Rob Phillips, Executive Chairman and Director of Clinical Science said “China has a sophisticated and rapidly evolving medical community and they are enthusiastic adopters of new technology and practice. This was a great opportunity to get the USCOM message to a very elite group of clinicians.”

This presentation coincided with the publication of new research at the prestigious Beijing Children’s Hospital in the Chinese Pediatric Emergency Medicine journal confirmed the accuracy of USCOM in children. This publication follows the prior publication of two other studies in the same journal over the last year.

Uscom has also received an order for an additional 10 units from Spacelabs Healthcare for the international market.

www.uscom.com.au

Uscom Limited Level 7, 8-10 Loftus Street Sydney NSW 2000 Australia Phone: 61-2-9247 4144 Fax: 61-2-9247 8157 ABN: 35 091 028 090

About Uscom

Uscom Limited is an Australian medical device company, listed on the Australian Stock Exchange since December 2003. Uscom has developed a device for the safe and accurate measurement of cardiac output, a non-invasive alternative to the current invasive methods. Uscom offers a completely safe, painless and quick method of accurately measuring how well the heart is pumping. With its real-time beat-to-beat information across multiple parameters of cardiac function and advanced serial measurement capabilities, clinicians can accurately quantify the impact of therapy. The device is ideally suited to the Emergency Care setting where it is critical to monitor changes in cardiac output as fluids are applied.

The Company has secured regulatory approval for sale of the Uscom Monitor in Australia, Europe and a number of Asian markets, including Japan, China and Taiwan. Uscom also has a CE Mark certification for Europe and a license from the State Food & Drug Administration for China. The Company received the necessary regulatory clearance for the United States market in February 2005 with the receipt of a 510K Pre Market Notification from the US Food & Drug Administration (FDA).

Uscom Contacts Paul Butler Chief Executive Officer Office: 02 9247 4144 paul.butler@uscom.com.au

Rob Phillips Executive Chairman Office: 02 9247 4144 rob@uscom.com.au

www.uscom.com.au

Uscom Limited Level 7, 8-10 Loftus Street Sydney NSW 2000 Australia Phone: 61-2-9247 4144 Fax: 61-2-9247 8157 ABN: 35 091 028 090